Vulvovaginal photodynamic therapy vs. topical corticosteroids in genital erosive lichen planus: A randomized controlled trial

British Journal of Dermatology

Volumn 173, Issue 5, 2015, Pages 1156-1162

  Helgesen, A L O ^a   Warloe, T ^a   Pripp, A H ^a   Kirschner, R ^a   Peng, Q ^a   Tanbo, T ^a   Gjersvik, P ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID HEXYL ESTER; CLOBETASOL PROPIONATE; HYDROCORTISONE ACETATE; AGENTS USED INTRAVAGINALLY; AMINOLEVULINIC ACID; CLOBETASOL; DERMATOLOGICAL AGENT; GLUCOCORTICOID; HYDROCORTISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEASIBILITY STUDY; FEMALE; GENITAL HERPES; GENITAL PAIN; HUMAN; LICHEN PLANUS; MICTURITION DISORDER; MIDDLE AGED; OBSERVATIONAL STUDY; PHOTODYNAMIC THERAPY; PHOTODYNAMIC THERAPY DEVICE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCIATICA; TREATMENT DURATION; VAGINA BLEEDING; VAGINA CANDIDIASIS; VAGINA DISEASE; VAGINAL ADHESION; VESTIBULAR NEURONITIS; VISUAL ANALOG SCALE; VULVOVAGINAL DISEASE; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; COMPARATIVE STUDY; CUTANEOUS DRUG ADMINISTRATION; INTRAVAGINAL DRUG ADMINISTRATION; PHOTOCHEMOTHERAPY; PROCEDURES; TREATMENT OUTCOME; VAGINAL DISEASES; VULVAR DISEASES;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, INTRAVAGINAL; AMINOLEVULINIC ACID; CLOBETASOL; DERMATOLOGIC AGENTS; FEASIBILITY STUDIES; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; LICHEN PLANUS; MIDDLE AGED; PHOTOCHEMOTHERAPY; TREATMENT OUTCOME; VAGINAL CREAMS, FOAMS, AND JELLIES; VAGINAL DISEASES; VULVAR DISEASES;

EID: 84983119385     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.14033     Document Type: Article

References (33)

1. Goldstein AT, Metz A,. Vulvar lichen planus. Clin Obstet Gynecol 2005; 48: 818-23.
2. Boyd AS, Neldner KH,. Lichen planus. J Am Acad Dermatol 1991; 25: 593-619.
3. Lewis FM, Bogliatto F,. Erosive vulval lichen planus-a diagnosis not to be missed: a clinical review. Eur J Obstet Gynecol Reprod Biol 2013; 171: 214-19.
4. Helgesen AL, Gjersvik P, Jebsen P, et al,. Vaginal involvement in genital erosive lichen planus. Acta Obstet Gynecol Scand 2010; 89: 966-70.
5. Cooper SM, Haefner HK, Abrahams-Gessel S, et al,. Vulvovaginal lichen planus treatment: a survey of current practices. Arch Dermatol 2008; 144: 1520-1.
6. Cooper SM, Ali I, Baldo M, et al,. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol 2008; 144: 1432-5.
7. Cheng S, Kirtschig G, Cooper S, et al,. Interventions for erosive lichen planus affecting mucosal sites. Cochrane Database Syst Rev 2012; 2: CD008092.
8. Anderson M, Kutzner S, Kaufman RH,. Treatment of vulvovaginal lichen planus with vaginal hydrocortisone suppositories. Obstet Gynecol 2002; 100: 359-62.
9. Bradford J, Fischer G,. Management of vulvovaginal lichen planus: a new approach. J Low Genit Tract Dis 2013; 17: 28-32.
10. Usatine RP, Tinitigan M,. Diagnosis and treatment of lichen planus. Am Fam Physician 2011; 84: 53-60.
11. Jensen JT, Bird M, Leclair CM,. Patient satisfaction after the treatment of vulvovaginal erosive lichen planus with topical clobetasol and tacrolimus: a survey study. Am J Obstet Gynecol 2004; 190: 1759-63.
12. Jang N, Fischer G,. Treatment of erosive vulvovaginal lichen planus with methotrexate. Australas J Dermatol 2008; 49: 216-19.
13. Peng Q, Warloe T, Berg K, et al,. 5-aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 1997; 79: 2282-308.
14. Ibbotson SH,. Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer. Br J Dermatol 2002; 146: 178-88.
15. Hillemanns P, Untch M, Prove F, et al,. Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid. Obstet Gynecol 1999; 93: 71-4.
16. Olejek A, Steplewska K, Gabriel A, et al,. Efficacy of photodynamic therapy in vulvar lichen sclerosus treatment based on immunohistochemical analysis of CD34, CD44, myelin basic protein, and Ki67 antibodies. Int J Gynecol Cancer 2010; 20: 879-87.
17. Kvaal SI, Warloe T,. Photodynamic treatment of oral lesions. J Environ Pathol Toxicol Oncol 2007; 26: 127-33.
18. Kvaal SI, Angell-Petersen E, Warloe T,. Photodynamic treatment of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol 2013; 115: 62-70.
19. Soergel P, Loning M, Staboulidou I, et al,. Photodynamic diagnosis and therapy in gynecology. J Environ Pathol Toxicol Oncol 2008; 27: 307-20.
20. Daayana S, Winters U, Stern PL, et al,. Clinical and immunological response to photodynamic therapy in the treatment of vulval intraepithelial neoplasia. Photochem Photobiol Sci 2011; 10: 802-9.
21. Hillemanns P, Untch M, Dannecker C, et al,. Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid. Int J Cancer 2000; 85: 649-53.
22. Hillemanns P, Petry KU, Soergel P, et al,. Efficacy and safety of hexaminolevulinate photodynamic therapy in patients with low-grade cervical intraepithelial neoplasia. Lasers Surg Med 2014; 46: 456-61.
23. Hillemanns P, Schneider A,. Response to the letters from W. Kuhn et al. and H. Griesser, K. Marquardt and B. Jordan on "Comments to the Publication of Munich Nomenclature III by the Cytology Coordination Conference" (Geburtsh Frauenheilk 2014; 74: 242-243). Geburtshilfe Frauenheilkd 2014; 74: 637-8.
24. Soergel P, Wang X, Stepp H, et al,. Photodynamic therapy of cervical intraepithelial neoplasia with hexaminolevulinate. Lasers Surg Med 2008; 40: 611-15.
25. Yang LP,. Hexaminolevulinate blue light cystoscopy: a review of its use in the diagnosis of bladder cancer. Mol Diagn Ther 2014; 18: 105-16.
26. Helgesen AL, Gjersvik P, Peng Q, et al,. Biodistribution of protoporphyrin IX in female genital erosive lichen planus after topical application of hexaminolevulinate. Photodiagnosis Photodyn Ther 2014; 11: 113-17.
27. Pelisse M,. The vulvo-vaginal-gingival syndrome. A new form of erosive lichen planus. Int J Dermatol 1989; 28: 381-4.
28. Cooper SM, Wojnarowska F,. Influence of treatment of erosive lichen planus of the vulva on its prognosis. Arch Dermatol 2006; 142: 289-94.
29. Lange N, Jichlinski P, Zellweger M, et al,. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study. Br J Cancer 1999; 80: 185-93.
30. Marti A, Lange N, van den Bergh H, et al,. Optimisation of the formation and distribution of protoporphyrin IX in the urothelium: an in vitro approach. J Urol 1999; 162: 546-52.
31. Andrejevic-Blant S, Major A, Ludicke F, et al,. Time-dependent hexaminolaevulinate induced protoporphyrin IX distribution after topical application in patients with cervical intraepithelial neoplasia: a fluorescence microscopy study. Lasers Surg Med 2004; 35: 276-83.
32. Simpson RC, Thomas KS, Murphy R,. Outcome measures for vulval skin conditions: a systematic review of randomized controlled trials. Br J Dermatol 2013; 169: 494-501.
33. Simpson RC, Thomas KS, Leighton P, et al,. Diagnostic criteria for erosive lichen planus affecting the vulva: an international electronic-Delphi consensus exercise. Br J Dermatol 2013; 169: 337-43.